Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis
Calgary, Alberta–(Newsfile Corp. – April 30, 2021) – Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF)…